col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


5 Ergebisse       Seite 1

 [1] 
S. Karger AG: Pharmacology
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2024―Jul―31 Negative prognostic associations of selective serotonin reuptake inhibitors use in hospitalized COVID-19 patients and potential contribution of cardiovascular comorbidities Ivan Papic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic
2 [GO] 2021―Sep―16 Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19 Mangaldeep Dey, Rakesh Kumar Singh
3 [GO] 2021―Aug―10 Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic Huda R. Taha, Nour Keewan, Farah Slati, Nour A. Al-Sawalha
4 [GO] 2021―Apr―29 Utilizing Artificial Intelligence to Manage COVID-19 Scientific Evidence Torrent with Risklick AI: A Critical Tool for Pharmacology and Therapy Development Quentin Haas, David Vicente Alvarez, Nikolay Borissov, Sohrab Ferdowsi, Leonhard von Meyenn, Sven Trelle, Douglas Teodoro, Poorya Amini
5 [GO] 2020―Okt―02 SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19? Morteza Ghasemnejad-Berenji, Sarvin Pashapour
 [1] 

5 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec